ストックスクリーナーアプリを入手
0.1316
2.73%
-0.0037
プレマーケット:
.14
0.0084
+6.38%
前日終値:
$0.1353
開ける：
$0.1338
24時間の取引高:
4.62M
Relative Volume:
1.81
時価総額：
$6.08M
収益：
$7.33M
当期純損益:
$-21.20M
株価収益率:
-0.1439
EPS:
-0.9143
ネットキャッシュフロー:
$-12.68M
1週間 パフォーマンス:
-27.29%
1か月 パフォーマンス:
-54.90%
6か月 パフォーマンス:
-65.73%
1年 パフォーマンス:
-81.46%
1日の値動き範囲:
$0.129
$0.14
1週間の範囲:
$0.1225
$0.22
52週間の値動き範囲:
$0.1225
$0.9349
Prophase Labs Inc Stock (PRPH) Company Profile
名前
Prophase Labs Inc
セクター
電話
(215) 345-0919
住所
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.1316 | 6.25M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-13 | ダウングレード | Dawson James | Buy → Neutral |
| 2021-01-20 | 開始されました | Dawson James | Buy |
Prophase Labs Inc (PRPH) 最新ニュース
MSN Money - MSN
Will Fed Rate Hikes Affect Kridhan Infra Limited Stocks OutlookValue Traps to Avoid & Get Free Expert Trading Recommendations - earlytimes.in
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... By GuruFocus - Investing.com Canada
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Inc (PRPH) Q3 2025 Earnings Call Highlights: Strategic Initiatives and Financial ... - Yahoo Finance
Prophase Labs Secures Forbearance Agreement with Avtech Capital - MSN
Prophase Labs Faces Unsealed Civil Action Disclosure - MSN
ProPhase Labs stockholders approve digital asset initiatives and stock split authority - Investing.com Australia
Prophase Labs Approves Strategic Proposals at Special Meeting - TipRanks
ProPhase Labs stockholders approve digital asset initiatives and stock split authority By Investing.com - Investing.com South Africa
ProPhase Labs investors approve digital asset powers and stock split plan - Stock Titan
ProPhase Labs (NASDAQ: PRPH) to Detail BE-Smart Cancer Test, $7–14B Market Opportunity - Stock Titan
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1 - sahmcapital.com
ProPhase Labs discloses unsealing of False Claims Act lawsuit in New York - Investing.com Nigeria
ProPhase Labs discloses unsealing of False Claims Act lawsuit in New York By Investing.com - Investing.com South Africa
ProPhase Labs updates payment schedule on Avtech equipment lease following Utah judgment - Investing.com Nigeria
ProPhase LabsOn Nov 21, received confirmation from AVTECH agreeing to continue its forbearance under co's existing equipment lease - marketscreener.com
ProPhase Labs updates payment schedule on Avtech equipment lease following Utah judgment By Investing.com - Investing.com South Africa
ProPhase Labs aware that civil action pending in the United States District Court for the Eastern District of New York has been unsealed - marketscreener.com
Prophase Labs- On Nov 21, Received Confirmation From Avtech Agreeing To Continue Its Forbearance Under Co's Existing Equipment Lease - TradingView
[8-K] ProPhase Labs, Inc. Reports Material Event | PRPH SEC FilingForm 8-K - Stock Titan
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2025 Earnings Call Transcript - MSN
ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances - MSN
Is ProPhase Labs Inc. stock vulnerable to regulatory risksForecast Cut & Advanced Technical Analysis Signals - newser.com
Reversal indicators forming on ProPhase Labs Inc. stock2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
ProPhase Labs Reports Q3 Loss Amid Strategic Shifts - TipRanks
Earnings call transcript: ProPhase Labs Q3 2025 posts unexpected EPS loss - Investing.com Nigeria
ProPhase Labs’ Earnings Call: Challenges and Opportunities - The Globe and Mail
What data driven models say about ProPhase Labs Inc.’s future - newser.com
ProPhase Labs Q3 2025 Earnings Call Transcript - MarketBeat
[10-Q] ProPhase Labs, Inc. Quarterly Earnings Report | PRPH SEC FilingForm 10-Q - Stock Titan
ProPhase Labs in talks for strategic initiative, cites undervalued assets By Investing.com - Investing.com Nigeria
ProPhase Labs, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PRPH) 2025-11-19 - Seeking Alpha
Prophase Labs Unveils Strategic Initiatives and Partnerships - MSN
ProPhase Labs, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025 - marketscreener.com
ProPhase Labs earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
ProPhase Labs reported results for the third quarter ended September 30, 2025, and will hold a virtual conference call today at 2pm ET. - marketscreener.com
ProPhase Labs (PRPH) Explores Strategic M&A Opportunities - GuruFocus
ProPhase Labs (PRPH) Q3 Revenue Decline but Future Prospects Bri - GuruFocus
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. - The Manila Times
ProPhase Labs in talks for strategic initiative, cites undervalued assets - Investing.com
ProPhase Labs Explores Strategic Initiatives to Unlock Company Value Amidst Key Developments in Crown Medical and BE-Smart™ Commercialization - Quiver Quantitative
Prophase Labs Inc (PRPH) 財務データ
収益
当期純利益
現金流量
EPS
0.86%
1.61%
大文字化:
|
ボリューム (24 時間):